ENTOD Pharmaceuticals CEO, in a statement, said he has assured the DCGI with a written undertaking that the company will fully comply with conditions outlined in the permission for PresVu eye drops, and make only approved claims; he has also appealed to the DCGI to reconsider the suspension
Eye drops for presbyopia: Pharma firm meets Drug Controller General of India, issues clarification
